相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
Karl Claxton et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
THE INFLUENCE OF COST-EFFECTIVENESS AND OTHER FACTORS ON NICE DECISIONS
Helen Dakin et al.
HEALTH ECONOMICS (2015)
Measuring and comparing health care waiting times in OECD countries
Luigi Siciliani et al.
HEALTH POLICY (2014)
Indicators of health system coverage and activity in Ireland during the economic crisis 2008-2014 - From 'more with less' to 'less with less'
Sara Burke et al.
HEALTH POLICY (2014)
The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation
[Anonymous]
HEALTH TECHNOLOGY ASSESSMENT (2014)
Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room
Simon Eckermann et al.
PHARMACOECONOMICS (2014)
NICE's Cost-Effectiveness Range: Should it be Lowered?
J. P. Raftery
PHARMACOECONOMICS (2014)
HTA INFORMED PRICE NEGOTIATIONS: COST SAVINGS TO THE HEALTH PAYER IN IRELAND
L. M. McCullagh et al.
VALUE IN HEALTH (2014)
SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE-BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS-SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN
Warren G. Linley et al.
HEALTH ECONOMICS (2013)
Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals
John Appleby et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2013)
How Much Should the NHS Pay for a QALY?
Alan Haycox
PHARMACOECONOMICS (2013)
Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland
Conor Teljeur et al.
TRANSFUSION (2012)
Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set
Helen Dakin et al.
BMJ OPEN (2012)
Value-Based Pricing Incentive for Innovation or Zero Net Benefit?
Dyfrig A. Hughes
PHARMACOECONOMICS (2011)
Pharmacoeconomic Evaluation in Ireland A Review of the Process
Lesley Tilson et al.
PHARMACOECONOMICS (2010)
Recent developments in pharmacoeconomic evaluation in Ireland
Lesley Tilson et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
How to assess the value of medicines?
Steven Simoens
FRONTIERS IN PHARMACOLOGY (2010)
The NICE cost-effectiveness threshold - What it is and what that means
Christopher McCabe et al.
PHARMACOECONOMICS (2008)
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Scott D Grosse
Expert Review of Pharmacoeconomics & Outcomes Research (2008)
Incremental cost-effectiveness ratios (ICERs): The silence of the lambda
A Gafni et al.
SOCIAL SCIENCE & MEDICINE (2006)
Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis
N Devlin et al.
HEALTH ECONOMICS (2004)
Use of cost-effectiveness analysis in health-care resource allocation decision-making:: How are cost-effectiveness thresholds expected to emerge?
HG Eichler et al.
VALUE IN HEALTH (2004)
Willingness to pay for a quality-adjusted life year: In search of a standard
RA Hirth et al.
MEDICAL DECISION MAKING (2000)
分享论文
